» Articles » PMID: 32097511

What is the Optimal Timing for Implant Placement in Oral Cancer Patients? A Scoping Literature Review

Overview
Journal Oral Dis
Specialty Dentistry
Date 2020 Feb 26
PMID 32097511
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Oral cancer patients can benefit from dental implant placement. Traditionally, implants are placed after completing oncologic treatment (secondary implant placement). Implant placement during ablative surgery (primary placement) in oral cancer patients seems beneficial in terms of early start of oral rehabilitation and limiting additional surgical interventions. Guidelines on the ideal timing of implant placement in oral cancer patients are missing.

Objective: To perform a scoping literature review on studies examining the timing of dental implant placement in oral cancer patients and propose a clinical practice recommendations guideline.

Methods: A literature search for studies dealing with primary and/or secondary implant placement in MEDLINE was conducted (last search December 27, 2019). The primary outcome was 5-year implant survival.

Results: Sixteen out of 808 studies were considered eligible. Both primary and secondary implant placement showed acceptable overall implant survival ratios with a higher pooled 5-year implant survival rate for primary implant placement 92.8% (95% CI: 87.1%-98.5%) than secondary placed implants (86.4%, 95% CI: 77.0%-95.8%). Primary implant placement is accompanied by earlier prosthetic rehabilitation after tumor surgery.

Conclusion: Patients with oral cancer greatly benefit from, preferably primary placed, dental implants in their prosthetic rehabilitation. The combination of tumor surgery with implant placement in native mandibular bone should be provided as standard care.

Citing Articles

Mandibular Reconstruction with Osseous Free Flap and Immediate Prosthetic Rehabilitation (Jaw-in-a-Day): In-House Manufactured Innovative Modular Stackable Guide System.

Ureel M, Bodere P, Denoiseux B, Corthouts P, Coopman R Bioengineering (Basel). 2025; 11(12.

PMID: 39768072 PMC: 11673054. DOI: 10.3390/bioengineering11121254.


Prosthetic Oral Rehabilitation with CAD/CAM Suprastructures in Patients with Severe Tissue Deficits: A Case Series.

Laurila M, Mantynen P, Mauno J, Suojanen J Dent J (Basel). 2023; 11(12).

PMID: 38132427 PMC: 10742847. DOI: 10.3390/dj11120289.


Implant-supported prosthetic rehabilitation after Ameloblastomas treatment: a systematic review.

Alarcon-Sanchez M, Becerra-Ruiz J, Yessayan L, Mosaddad S, Heboyan A BMC Oral Health. 2023; 23(1):1013.

PMID: 38110933 PMC: 10729555. DOI: 10.1186/s12903-023-03765-7.


Towards Optimum Mandibular Reconstruction for Dental Occlusal Rehabilitation: From Preoperative Virtual Surgery to Autogenous Particulate Cancellous Bone and Marrow Graft with Custom-Made Titanium Mesh-A Retrospective Study.

Onodera K, Miyamoto I, Hoshi I, Kawamata S, Takahashi N, Shimazaki N J Clin Med. 2023; 12(3).

PMID: 36769770 PMC: 9918119. DOI: 10.3390/jcm12031122.


Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients-A Feasibility Study.

Valdec S, Bosshard F, Hullner M, Schwaninger D, Stocker L, Giacomelli-Hiestand B Front Med (Lausanne). 2022; 9:809323.

PMID: 35386916 PMC: 8977518. DOI: 10.3389/fmed.2022.809323.


References
1.
Wetzels J, Koole R, Meijer G, de Haan A, Merkx M, Speksnijder C . Functional benefits of implants placed during ablative surgery: A 5-year prospective study on the prosthodontic rehabilitation of 56 edentulous oral cancer patients. Head Neck. 2016; 38 Suppl 1:E2103-11. DOI: 10.1002/hed.24389. View

2.
Chrcanovic B, Albrektsson T, Wennerberg A . Dental implants in irradiated versus nonirradiated patients: A meta-analysis. Head Neck. 2014; 38(3):448-81. DOI: 10.1002/hed.23875. View

3.
Said M, Otomaru T, Sumita Y, Leung K, Khan Z, Taniguchi H . Systematic review of literature: functional outcomes of implant-prosthetic treatment in patients with surgical resection for oral cavity tumors. J Investig Clin Dent. 2016; 8(2). DOI: 10.1111/jicd.12207. View

4.
Spijkervet F, Brennan M, Peterson D, Witjes M, Vissink A . Research Frontiers in Oral Toxicities of Cancer Therapies: Osteoradionecrosis of the Jaws. J Natl Cancer Inst Monogr. 2019; 2019(53). DOI: 10.1093/jncimonographs/lgz006. View

5.
Kamstra J, Jager-Wittenaar H, Dijkstra P, Huisman P, van Oort R, van der Laan B . Oral symptoms and functional outcome related to oral and oropharyngeal cancer. Support Care Cancer. 2010; 19(9):1327-33. PMC: 3151373. DOI: 10.1007/s00520-010-0952-4. View